Anavex Life Sciences Corp (AVXL)

[sokol]

I will have to reply more about this later. But just for now, the U.S. FDA exclusivity only has application in the U.S. Therefore, the Greek patents have no relation to the FDA exclusivity, which FDA exclusivity starts to run once the FDA approves the drug in the U.S. Also, the assignment of the invention by the inventors may cover more than just any patents the inventors may have filed in Greece or elsewhere. We are not privy to the assignments, but I am just thinking the assignments were very broad. Also, I really do not know that much about Greek patents -- how long they run, etc. Am I making sense though about everything else other than the Greek patents that I may try to discover more about?